Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glucocorticoids and prostate cancer treatment: friend or foe?

Asian journal of andrology - 1 Jan 2000

Montgomery Bruce, Cheng Heather H, Drechsler James, Mostaghel Elahe A

Abstract excerpt

Glucocorticoids have been used in the treatment of prostate cancer to slow disease progression, improve pain control and offset side effects of chemo- and hormonal therapy. However, they may also have the potential to drive prostate cancer growth via mutated androgen receptors or glucocorticoid receptors (GRs). In this review we examine historical and contemporary use of glucocorticoids in the treatment of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Androgen Antagonists
Share to Antineoplastic Agents, Hormonal
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Glucocorticoids

Share to Mutation

Share to Prostatic Neoplasms

Share to Prostatic Neoplasms, Castration-Resistant

Share to Receptors, Glucocorticoid

Source

Open in PubMed Open full text

Identifiers

PMID: 24625881
DOI: 10.4103/1008-682X.125392
PMCID: PMC4023359

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glucocorticoids and prostate cancer treatment: friend or foe?PMID 24625881Read ↗

Glucocorticoid receptor action in prostate cancer: the role of transcription factor crosstalkSemantic proximity Read ↗

Androgens and prostate cancer.Semantic proximity Read ↗

Glucocorticoids manifest androgenic activity in a cell line derived from a metastatic prostate cancer.Semantic proximity Read ↗

Glucocorticoid signaling delays castration-induced regression in murine models of prostate cancerSemantic proximity Read ↗

Endocrine Disruptors and Prostate CancerSemantic proximity Read ↗

Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancerSemantic proximity Read ↗

[Recent trend in the development of novel treatments based on the mechanisms of prostate cancer progression].Semantic proximity Read ↗

Preclinical and Clinical Research Models of Prostate Cancer: A Brief OverviewSemantic proximity Read ↗

Androgen receptor-mediated assisted loading of the glucocorticoid receptor modulates transcriptional responses in prostate cancer cellsSemantic proximity Read ↗

Mechanisms of androgen-refractory prostate cancer.Semantic proximity Read ↗

Duality of glucocorticoid action in cancer: tumor-suppressor or oncogene?Semantic proximity Read ↗

The Metabolism, Analysis, and Targeting of Steroid Hormones in Breast and Prostate Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.